albumin paclitaxel + lobaplatin

**albumin paclitaxel + lobaplatin** is a combination chemotherapy regimen used in the treatment of certain cancers, notably non-squamous non-small cell lung cancer (NS-NSCLC) with malignant pleural effusion and locally advanced esophageal squamous cell carcinoma. Albumin paclitaxel (nab-paclitaxel) is a nanoparticle albumin-bound formulation of paclitaxel, which enhances drug delivery and reduces toxicity compared to traditional solvent-based formulations. Lobaplatin is a third-generation platinum-based antineoplastic agent with lower toxicity than earlier platinum drugs. **Mechanism of Action:** - **Albumin Paclitaxel:** Binds to tubulin, stabilizing microtubules and inhibiting their disassembly, leading to mitotic arrest and apoptosis in rapidly dividing cells[4][9]. - **Lobaplatin:** Forms DNA adducts that interfere with DNA replication and transcription, inducing apoptosis in cancer cells[2].

Other names

nab-paclitaxel + lobaplatinalbumin-bound paclitaxel + lobaplatinABP + LBP